✦ LIBER ✦

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

✍ Scribed by L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; B. Musch

Book ID: 118601608
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 291 KB
Volume: 9
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(99)80446-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of galanta

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial

✍ T. Pirttilä; G. Wilcock; L. Truyen; C. V. Damaraju 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

✍ X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

Efficacy and safety of once-daily inhale

Efficacy and safety of once-daily inhaled ciclesonide in adults with mild to moderate asthma: A double-blind, placebo-controlled study

✍ Mitsuru ADACHI; Kyosuke ISHIHARA; Hiroshi INOUE; Koichiro KUDO; Kiyoshi TAKAHASH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Melissa officinalis extract in the treat

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

P1-383 Cerebrolysin-efficacy and safety

P1-383 Cerebrolysin-efficacy and safety in moderate to moderately severe Alzheimer's disease: subgroup analysis of a randomized, double-blind, placebo-controlled trial

✍ Herbert Moessler; Antòn X. Álvarez; Ramón Cacabelos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB